Bruno Lucidi Atea Pharmaceuticals, Inc. (AVIR) insider trading activity
Bruno Lucidi is of Atea Pharmaceuticals, Inc.. Currently has a direct ownership of 83,150 shares of AVIR, which is worth approximately $270,237. The most recent transaction as insider was on Jun 16, 2024, when has been sold 33,150 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
83.2K
0%
3M change
n/a
12M change
Total Value Held
$270,237
BL
Bruno Lucidi
Boston, MA